F Fuzkk Atlas of the EU, Switzerland, the United Kingdom and Israel
#9Regional leaders 1–100

Merck KGaA

Germany · European Union

Diversified pharmaFinished dosage forms and small molecules

Manufacturing profile

Country
Germany
Regulatory region
European Union
ISO
DEU

Selection basis

The company is placed in positions 1–100 as a major regional manufacturer, biopharmaceutical group, important generics supplier or manufacturing/CDMO leader.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1Portfolio of products and sites
  2. 2Multiple manufacturing process types
  3. 3Shared supplier, validation and data controls
  4. 4Product-specific and instrumental QC
  5. 5Group QMS, release and lifecycle evidence
  6. 6Raw-material receipt and identification
  7. 7Dispensing, blending and granulation
  8. 8Tableting, encapsulation or solution preparation
  9. 9Packaging and labelling

Relevant FUZKK packages

Germany: national essential medicines QC packageLumex QC SuiteLabEx QC SuiteMedical Device QMS SuiteGlobal API & Biosimilars QC Suite

Product/API utilities

Assay & Impurities Result Reviewer

Lumex — instrumental QC

Genotoxic Impurity Screener M7Content Uniformity Acceptance ValueSystem Suitability Parameters Checker

LabEx — laboratory QC

Assay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality CheckerElemental Impurities ICP Quality CheckerContent Uniformity Quality CheckerDissolution Apparatus 1 & 2 Quality CheckerStability Condition Monitoring Quality Checker

Medical Devices — equipment and software lifecycle

Release Readiness CheckerSupplier Evaluation CheckerCalibration Status CheckerProcess Validation CheckerChange Control Impact CheckerData Integrity Security CheckerRequirement Traceability Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Methodology